Beth's expertise includes the complexity of data sources and their interface with clinical databases, data monitoring, the CRO landscape, and Good Clinical Practice. Her therapeutic area expertise includes oncology, CNS, and clinical pharmacology.

As the president of Trialwise, a boutique CRO she founded in 1995,  Beth regularly consults with a small number of select private and government clients, and directs clinical research for Phase 1 and 2 studies. 

Prior to founding Trialwise, Beth provided operational oversight for early and late phase programs for Fortune 500 companies, including global submissions of blockbuster products. She is a frequent speaker and trainer on topics including Good Clinical Practices and optimized clinical study workflow at national conferences.

Beth studied psychology and zoology at Brigham Young University and holds an MBA from the C.T. Bauer College of Business at the University of Houston.

In her more than 20 years of experience in clinical research, Beth Brinsdon has developed a valued, thorough, and nuanced understanding of investigational product development and what it takes to execute clinical trials. 

Beth Brinsdon

President and Founder